DE69520475T2 - Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen - Google Patents

Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen

Info

Publication number
DE69520475T2
DE69520475T2 DE69520475T DE69520475T DE69520475T2 DE 69520475 T2 DE69520475 T2 DE 69520475T2 DE 69520475 T DE69520475 T DE 69520475T DE 69520475 T DE69520475 T DE 69520475T DE 69520475 T2 DE69520475 T2 DE 69520475T2
Authority
DE
Germany
Prior art keywords
proteins
pharmaceutical composition
biologically active
active peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520475T
Other languages
English (en)
Other versions
DE69520475D1 (de
Inventor
Makoto Sato
Toshiyuki Kouzaki
Yoko Ishihara
Shigeaki Yoshina
Masanao Nakoshi
Tatsushi Maeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of DE69520475D1 publication Critical patent/DE69520475D1/de
Publication of DE69520475T2 publication Critical patent/DE69520475T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2214—Motilins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69520475T 1994-07-22 1995-07-10 Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen Expired - Fee Related DE69520475T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6171070A JPH0827018A (ja) 1994-07-22 1994-07-22 生理活性ペプチド又は蛋白質を含有する薬剤組成物

Publications (2)

Publication Number Publication Date
DE69520475D1 DE69520475D1 (de) 2001-05-03
DE69520475T2 true DE69520475T2 (de) 2001-09-27

Family

ID=15916480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520475T Expired - Fee Related DE69520475T2 (de) 1994-07-22 1995-07-10 Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen

Country Status (4)

Country Link
US (1) US5733877A (de)
EP (1) EP0706798B1 (de)
JP (1) JPH0827018A (de)
DE (1) DE69520475T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192319A1 (en) * 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8206749B1 (en) * 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7960416B2 (en) * 2001-08-03 2011-06-14 Takeda Pharmaceutical Company Limited Stable emulsion composition
IL145926A0 (en) * 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
CN100354306C (zh) 2002-10-11 2007-12-12 株式会社三和化学研究所 Glp－1衍生物及其经粘膜吸收的制剂
IL155136A0 (en) * 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
ES2348303T3 (es) * 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
CN101035594B (zh) * 2004-08-09 2013-10-23 酶学技术有限公司 用于糖尿病患者的食品
KR101323513B1 (ko) 2004-08-10 2013-10-29 엔지모테크 리미티드 의학적 증상의 치료에서의 사용을 위한 피토스테롤에스테르(들) 및 1,3-디글리세라이드(들)의 혼합물
US8062333B2 (en) * 2005-02-17 2011-11-22 Anpa Medical, Inc. Suture retainer with multiple circumferentially spaced attachment points and suture retention method
EP1896500A4 (de) * 2005-06-28 2010-08-11 Yeda Res & Dev Gliomedin, fragmente davon und verfahren zu ihrer anwendung
AU2006293420B2 (en) * 2005-09-22 2011-06-30 Irun R. Cohen Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
US20100150924A1 (en) * 2007-05-22 2010-06-17 Elior Peles Regulation of myelination by nectin-like (necl) molecules
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
WO2016069983A1 (en) 2014-10-31 2016-05-06 Merial, Inc. Parasiticidal composition comprising fipronil

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564512A (en) * 1978-11-11 1980-05-15 Kanebo Ltd Cosmetic composition of oil-in-water emulsion
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS59216820A (ja) 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
JPS61263914A (ja) 1985-05-17 1986-11-21 Yutaka Mizushima リピツドマイクロスフエア−
JPS62284000A (ja) 1986-05-31 1987-12-09 Yutaka Mizushima 生理活性蛋白結合リピッドマイクロスフェア−
IT1204400B (it) * 1986-06-20 1989-03-01 Sclavo Spa Composizioni farmaceutiche contenente una calcitonina
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
DE4015108A1 (de) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
US5578323A (en) * 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides

Also Published As

Publication number Publication date
DE69520475D1 (de) 2001-05-03
US5733877A (en) 1998-03-31
JPH0827018A (ja) 1996-01-30
EP0706798A1 (de) 1996-04-17
EP0706798B1 (de) 2001-03-28

Similar Documents

Publication Publication Date Title
DE69900746D1 (de) Gesteuerte verabreichung von peptiden oder proteinen
DE69520475T2 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
ZA941771B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
ATE217787T1 (de) Aerosolformulierungen mit peptiden und proteinen
DE69424576D1 (de) Biologisch aktive tgf-beta1 und tgf-beta2 peptide
BR9407583A (pt) Processos para produzir uma proteina bcl-2 mutante para identificar agentes modulantes de bcl-2 candidatos um bcl-2 mutante e proteinas bcl-2 mutantes e para inibir a atividade repressora de morte de células de bcl-2 e polipeptideo bcl-2 mutante
AU3321595A (en) Recombinant production of biologically active peptides and proteins
DE3685626D1 (de) Sequenzierung von peptiden.
DE69132708T2 (de) Therapeutische Vervendung von Peptiden mit Thrombospondin - ähnlicher Aktivität
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
ATE230926T1 (de) Synergistische mischungen von ausgewählten aminosäuren
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
DE69123345T2 (de) Sequenzielle c-termin degradierung von peptiden und proteinen
DK109590A (da) Biologisk aktivt protein
BR9604938A (pt) Vírus recombinante deficiente utilização deste vírus composição farmacêutica e célula de mamífero
ATE198469T1 (de) Verbesserung der verträglichkeit von pharmazeutisch wirksamen beta-aminosäuren
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
NL1000332C1 (nl) Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.
DE69030316T2 (de) Schrittweiser c-terminaler abbau von peptiden und proteinen
DE3869939D1 (de) Biologisch wirksame peptide.
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
DE69420044T2 (de) Blutregulierende peptide
ZA947133B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee